Is Applied Therapeutics Inc (APLT) overvalued? · rev $455.0K
Applied Therapeutics Inc (APLT) is a biotechnology company listed on US.
This page asks whether Applied Therapeutics Inc (APLT) looks expensive on cached numbers — not a short thesis.
Latest reported APLT revenue for 2024-12-31 was $455.0K. Net income was -$105.6M. APLT currently screens at market cap $14.9M.
APLT currently screens at market cap $14.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next APLT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the APLT stock page for the full model, not this heading.
Not investment advice.